Record #71580
Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway
Publisher
Original paper date
Jan 8, 2022
Original DOI
Country
Institution
Department of Neurosurgery, Jinling Hospital, School of Medicine, Southeast University, 305 East Zhongshan Road, Nanjing, 210002, Jiangsu, China · Department of Neurosurgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002, Jiangsu, China · Department of Neurosurgery, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, 210002, China
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
30
Same day
0
Post-retraction
1
% post-retraction
3.2%
~7.2 citations/yr before retraction · ~2.0 citations/yr after
— citing papers
Who is still citing this work
Loading…